Literature DB >> 9121305

KTP laser and neutral red phototherapy of human squamous cell carcinoma.

Q M VanderWerf1, D J Castro, R D Nguyen, M B Paiva, K H Chao, M E Santillanes, R E Saxton.   

Abstract

Neutral red (NR) is a cationic, nontoxic vital dye employed as a histologic stain for proliferating cells; it has been used clinically for photodynamic treatment of herpes simplex virus lesions. NR is selectively taken up and concentrated by mitotic cells, an important characteristic for more effective antineoplastic agents. In the present study, UCLA-SO-P3 human squamous carcinoma cells displayed minimal toxicity when incubated with up to 50 microg/ml NR in the absence of light. However, cells incubated with greater than 0.5 microg/ml NR followed by exposure to KTP laser light at 532 nm exhibited nearly 100% tumor cell death. The degree of cell toxicity was proportional to NR dose and laser light fluence. This study demonstrates that NR is an excellent cancer cell photosensitizer in vitro, and, after adding additional in vivo preclinical testing, may prove to be a useful agent in photodynamic destruction of head and neck tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121305     DOI: 10.1097/00005537-199703000-00007

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Photodynamic effect of argon and diode laser on cholesteatoma cell cultures after intravital staining with absorption enhancers.

Authors:  B Sedlmaier; A Franke; H Sudhoff; S Jovanovic; A Haisch
Journal:  Lasers Med Sci       Date:  2005-03-17       Impact factor: 3.161

2.  Neutral red as a probe for confocal laser scanning microscopy studies of plant roots.

Authors:  Joseph G Dubrovsky; Martin Guttenberger; Andres Saralegui; Selene Napsucialy-Mendivil; Boris Voigt; Frantisek Baluska; Diedrik Menzel
Journal:  Ann Bot       Date:  2006-03-06       Impact factor: 4.357

3.  Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.

Authors:  Philipp P Caffier; Ulrike Marzahn; Andrea Franke; Holger Sudhoff; Sergije Jovanovic; Andreas Haisch; Benedikt Sedlmaier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-06       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.